Advanced technology. Exacting standards.

Implant Sciences Corporation (IMSC:OTCPK) develops and commercializes explosives trace detection (ETD) solutions for transportation and aviation security, force protection and law enforcement, critical infrastructure protection, and public safety markets.

Founded in 1984, Implant Sciences has a rich history of developing leading technologies in several markets. The company today is a pure play in global Security, Safety, and Defense (SS&D) markets. The Company's patented technology, used in its flagship product, the Quantum Sniffer™ QS-H150 handheld explosives trace detector, is in use throughout the world.

IMSC successfully introduced its first handheld explosive trace detection product in 2003 and has sold more than 1,100 ETD systems, generating over $25 million in revenues. The global ETD market is project to grow to approximately $1 billion by 2014.

The QS-H150 has been Designated a Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security pursuant to 6 U.S.C. § 441-444 (the Support Anti-terrorism by Fostering Effective Technologies Act of 2002, or "SAFETY Act") and 6 C.F.R. Part 25 (Regulations to Support Anti-terrorism by Fostering Effective Technologies).